The triple negative breast cancer (TNBC) is characterized by a lack of estrogen or progesterone receptor expression as well as of human epidermal growth factor receptor 2 (ERBB2/HER2) [3]. Here, ERBB2 is linked to triple-negative breast carcinoma.